S&P 500 · 업종 · 60기업
S&P 500의 헬스케어 주식
최근 회계연도 기준으로 이 업종 기업들의 매출 합계는 $3.66조, 순이익은 $1,960억(매출의 5.4%)입니다. 매출이 가장 큰 기업은 UnitedHealth Group입니다.
최근 회계연도 매출 합계, 60기업
$3.66조연 +9.1%
10년간 매출 증가율 중앙값(53기업)
기업
60
세부 업종: 10개
순이익 합계
$1,960억
매출 5.4%
순이익률 중앙값
13.0%
최근 회계연도
배당 지급
60 중 37
데이터상 매년 인상: 7기업
10년 전보다 적은 주식 수
57 중 31
변화 중앙값 −5.8%
2010년 이후 매출과 순이익 합계
모든 해의 수치가 있는 기업(48곳)의 매출은 2010년 $9,800억에서 2025년 $3.33조 수준으로 변했습니다(연 8.5%).
매출순이익
차트 데이터를 불러오지 못했습니다. 아래 표에 같은 수치가 있습니다.
기업
| UnitedHealth Group | UNH | Managed Health Care | 2025 | $4,480억 | $121억 | 2.7% | 11.7% | 11.0% | 8.2% | $8.73 | 16 | −5.8% |
| McKesson | MCK | Health Care Distributors | 2026 | $4,030억 | $47.6억 | 1.2% | 11.1% | 7.8% | 14.7% | $3.17 | 13 | −46.7% |
| CVS Health | CVS | Health Care Services | 2025 | $4,020억 | $17.7억 | 0.4% | 8.4% | 10.1% | −11.3% | $2.66 | 0 | +12.9% |
| COR | Health Care Distributors | 2025 | $3,210억 | $15.5억 | 0.5% | 11.1% | 9.0% | — | $2.20 | 17+ | −10.4% | |
| Cigna | CI | Health Care Services | 2025 | $2,750억 | $59.6억 | 2.2% | 11.4% | 21.9% | 10.7% | $6.04 | 5 | +3.1% |
| CAH | Health Care Distributors | 2026 | $2,540억 | $17.1억 | 0.7% | 9.4% | 7.7% | 5.3% | $2.04 | 18+ | −28.2% | |
| ELV | Managed Health Care | 2025 | $1,990억 | $56.6억 | 2.8% | 10.3% | 9.7% | 10.4% | $6.84 | 14 | −17.7% | |
| CNC | Managed Health Care | 2025 | $1,950억 | −$66.7억 | −3.4% | 11.9% | 23.9% | — | — | — | +100.3% | |
| HUM | Managed Health Care | 2025 | $1,300억 | $11.9억 | 0.9% | 10.9% | 9.1% | 1.5% | $3.54 | 0 | −20.1% | |
| Johnson & Johnson | JNJ | Pharmaceuticals | 2025 | $942억 | $268억 | 28.5% | 2.7% | 3.0% | 7.2% | $5.14 | 18+ | −13.6% |
| HCA | Health Care Facilities | 2025 | $756억 | $67.8억 | 9.0% | 8.0% | — | 19.0% | $2.88 | 5 | −43.9% | |
| LLY | Pharmaceuticals | 2025 | $652억 | $206억 | 31.7% | 21.6% | 12.6% | 26.1% | $6.23 | 9 | −15.6% | |
| MRK | Pharmaceuticals | 2025 | $650억 | $183억 | 28.1% | 9.4% | 5.1% | 16.7% | $3.28 | 15 | −11.8% | |
| PFE | Pharmaceuticals | 2025 | $626억 | $77.7억 | 12.4% | 8.5% | 2.5% | 2.1% | $1.72 | 15 | −8.7% | |
| ABBV | Biotechnology | 2025 | $612억 | $42.3억 | 6.9% | 6.0% | 10.3% | −2.8% | $6.65 | 11 | +8.3% | |
| BMY | Pharmaceuticals | 2025 | $482억 | $70.5억 | 14.6% | 2.5% | 11.3% | 14.0% | $2.49 | 18+ | +21.4% | |
| TMO | Life Sciences Tools & Services | 2025 | $446억 | $67억 | 15.0% | 6.7% | 10.1% | 13.7% | $1.72 | 8 | −6.0% | |
| ABT | Health Care Equipment | 2025 | $443억 | $65.2억 | 14.7% | 5.1% | 8.1% | 2.5% | $2.40 | 3 | +16.1% | |
| AMGN | Biotechnology | 2025 | $368억 | $77.1억 | 21.0% | 7.6% | 5.4% | 4.6% | $9.66 | 12 | −29.2% | |
| MDT | Health Care Equipment | 2026 | $364억 | $48억 | 13.2% | 3.8% | 2.3% | 4.2% | $2.84 | 18+ | −9.7% | |
| Gilead Sciences | GILD | Biotechnology | 2025 | $294억 | $85.1억 | 28.9% | 3.6% | −1.0% | −5.5% | $3.16 | 10 | −17.5% |
| SYK | Health Care Equipment | 2025 | $251억 | $32.5억 | 12.9% | 11.8% | 9.7% | 8.3% | $3.40 | 16 | +1.5% | |
| DHR | Life Sciences Tools & Services | 2025 | $246억 | $36.1억 | 14.7% | 2.0% | — | 0.6% | — | — | +1.1% | |
| BDX | Health Care Equipment | 2025 | $218억 | $16.8억 | 7.7% | 6.3% | 7.8% | 5.7% | $4.16 | 12 | +39.0% | |
| GE HealthCare | GEHC | Health Care Equipment | 2025 | $206억 | $20.8억 | 10.1% | — | — | — | $0.14 | 2+ | — |
| BSX | Health Care Equipment | 2025 | $201억 | $29억 | 14.4% | 15.2% | 10.4% | — | — | — | +11.4% | |
| UHS | Health Care Facilities | 2025 | $174억 | $14.9억 | 8.6% | 8.5% | 6.7% | 13.1% | $0.80 | 0 | −36.0% | |
| IQV | Life Sciences Tools & Services | 2025 | $163억 | $13.6억 | 8.3% | 7.5% | 11.0% | 9.8% | — | — | +38.1% | |
| Regeneron Pharmaceuticals | REGN | Biotechnology | 2025 | $143억 | $45억 | 31.4% | 11.0% | 13.3% | 22.3% | $3.52 | 0 | −5.8% |
| VTRS | Pharmaceuticals | 2025 | $143억 | −$35.1억 | −24.6% | 3.7% | 4.3% | — | $0.48 | 0 | +134.6% | |
| Labcorp | LH | Health Care Services | 2025 | $140억 | $8.77억 | 6.3% | −0.0% | 4.9% | 9.2% | $2.88 | 0 | −16.7% |
| DVA | Health Care Services | 2025 | $136억 | $7.47억 | 5.5% | 3.4% | — | 22.9% | — | — | −64.9% | |
| Henry Schein | HSIC | Health Care Distributors | 2025 | $132억 | $3.98억 | 3.0% | 5.4% | — | 1.4% | — | — | −27.7% |
| VRTX | Biotechnology | 2025 | $120억 | $39.5억 | 32.9% | 14.1% | 27.8% | — | — | — | +6.9% | |
| BAX | Health Care Equipment | 2025 | $112억 | −$9.57억 | −8.5% | −0.7% | 1.2% | — | $0.52 | 0 | −6.6% | |
| Quest Diagnostics | DGX | Health Care Services | 2025 | $110억 | $9.92억 | 9.0% | 3.2% | 3.9% | 6.0% | $3.20 | 15 | −22.1% |
| ISRG | Health Care Equipment | 2025 | $101억 | $28.6억 | 28.4% | 18.2% | 15.5% | 16.4% | — | — | +6.3% | |
| Biogen | BIIB | Biotechnology | 2025 | $98.9억 | $12.9억 | 13.1% | −6.0% | −0.8% | −5.4% | — | — | −36.4% |
| ZTS | Pharmaceuticals | 2025 | $94.7억 | $26.7억 | 28.2% | 7.2% | 7.1% | 24.4% | $2.03 | 12 | −11.6% | |
| SOLV | Health Care Technology | 2025 | $83.2억 | $15.6억 | 18.7% | — | — | — | — | — | — | |
| ZBH | Health Care Equipment | 2025 | $82.3억 | $7.05억 | 8.6% | 6.1% | 3.2% | 16.5% | $0.96 | 0 | +4.7% | |
| A | Life Sciences Tools & Services | 2025 | $69.5억 | $13억 | 18.8% | 5.4% | 5.6% | 14.3% | $0.99 | 10 | −14.9% | |
| EW | Health Care Equipment | 2025 | $60.7억 | $10.7억 | 17.7% | 6.7% | 9.3% | 9.3% | — | — | −11.4% | |
| STE | Health Care Equipment | 2026 | $59.4억 | $7.82억 | 13.2% | 13.8% | 10.2% | 17.7% | $2.46 | 15 | +38.7% | |
| RMD | Health Care Equipment | 2026 | $56.5억 | $15.2억 | 26.9% | 12.1% | 11.9% | 15.4% | $2.40 | 5 | +3.1% | |
| INCY | Biotechnology | 2025 | $51.4억 | $12.9억 | 25.0% | 14.0% | 21.2% | 71.0% | — | — | +7.2% | |
| Dexcom | DXCM | Health Care Equipment | 2025 | $46.6억 | $8.36억 | 17.9% | 19.3% | 27.8% | — | — | — | +27.0% |
| ILMN | Life Sciences Tools & Services | 2025 | $43.4억 | $8.5억 | 19.6% | 6.0% | 6.9% | 5.8% | — | — | +4.7% | |
| IDXX | Health Care Equipment | 2025 | $43억 | $10.6억 | 24.6% | 9.7% | 10.4% | 20.4% | — | — | −13.5% | |
| COO | Health Care Supplies | 2025 | $40.9억 | $3.75억 | 9.2% | 11.0% | 8.6% | 6.1% | — | — | +1.6% | |
| ALGN | Health Care Supplies | 2025 | $40.3억 | $4.1억 | 10.2% | 10.3% | 16.9% | 12.3% | — | — | −11.0% | |
| MTD | Life Sciences Tools & Services | 2025 | $40.3억 | $8.69억 | 21.6% | 5.5% | 5.3% | 12.9% | — | — | −26.9% | |
| CRL | Life Sciences Tools & Services | 2025 | $40.2억 | −$1.44억 | −3.6% | 6.5% | 11.4% | — | — | — | +4.1% | |
| VEEV | Health Care Technology | 2026 | $32억 | $9.09억 | 28.4% | 16.9% | 22.8% | 30.5% | — | — | +15.2% | |
| Waters Corporation | WAT | Life Sciences Tools & Services | 2025 | $31.7억 | $6.43억 | 20.3% | 6.0% | 4.5% | 6.7% | — | — | −28.1% |
| West Pharmaceutical Services | WST | Health Care Supplies | 2025 | $30.7억 | $4.94억 | 16.1% | 7.4% | 8.2% | 18.0% | $0.86 | 17+ | −1.5% |
| RVTY | Health Care Equipment | 2025 | $28.6억 | $2.41억 | 8.4% | 1.4% | 3.1% | 1.0% | $0.28 | 0 | +2.9% | |
| Insulet Corporation | PODD | Health Care Equipment | 2025 | $27.1억 | $2.47억 | 9.1% | 24.5% | 26.2% | — | — | — | +26.6% |
| MRNA | Biotechnology | 2025 | $19.4억 | −$28.2억 | −145.2% | 19.3% | — | — | — | — | — | |
| Bio-Techne | TECH | Life Sciences Tools & Services | 2026 | $12.2억 | $1.82억 | 15.0% | 5.5% | 9.3% | 5.2% | $0.32 | 0 | +5.2% |
매출과 순이익: 가장 최근의 전체 회계연도(FY) 기준입니다. 성장률: 5년 또는 10년간의 연평균 증가율입니다. 배당: 최근 연도의 1주당 배당입니다. 연속 인상: 주당 배당이 계속 높아진 연수입니다. SEC 데이터는 2009년부터 시작하며(2007~2008년은 비교 연도), +는 기업의 수치가 시작되는 시점까지 거슬러 올라가는 기록임을 뜻합니다. 주식 수, 10년: 주식 수의 변화이며, 0 미만은 자사주 매입을 뜻합니다. —: 데이터에 없거나 의미가 없음.
다른 업종
출처: SEC EDGAR(기업 공시), 2026년 11월 13일 기준 데이터. 업종, 세부 업종, 본사 소재지, 지수 편입일: Wikipedia, CC BY-SA 4.0.